• Citer

Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis

par Martel, Samuel;Bruzzone, Marco;Ceppi, Marcello;Maurer, Christian;Pondé, Noam;Ferreira, Arlindo A.R.;Viglietti, Giulia ;Del Mastro, Lucia;Prady, Catherine;de Azambuja, Evandro ;Lambertini, Matteo
Référence Cancer treatment reviews, 62, page (123-132)
Publication Publié, 2018-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis
Auteur:	Martel, Samuel; Bruzzone, Marco; Ceppi, Marcello; Maurer, Christian; Pondé, Noam; Ferreira, Arlindo A.R.; Viglietti, Giulia; Del Mastro, Lucia; Prady, Catherine; de Azambuja, Evandro; Lambertini, Matteo
Informations sur la publication:	Cancer treatment reviews, 62, page (123-132)
Statut de publication:	Publié, 2018-01
Sujet CREF:	Imagerie médicale, radiologie, tomographie
	Cancérologie
Mots-clés:	Adverse events
	Endocrine therapy
	Hormone-receptor positive
	Metastatic breast cancer
	Targeted therapy
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:0305-7372
	info:doi/10.1016/j.ctrv.2017.09.009
	info:pii/S0305737217301548
	info:scp/85032951699
	info:pmid/29108713